Topoblock
Brand Name: Topoblock
Generic Name: Irinotecan Hydrochloride
Active
Registration Number
DRP-4116-01
Dosage Form
Solution for Injection (IV)
Issuance Date
November 28, 2022
Expiry Date
November 3, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength20mg/mL
Packaging40mg/2mL USP Type I Amber Glass Tubular Vial per Box and 100mg/5mg USP Type I Amber Glass Tubular Vial per Box
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Anti-neoplastic (cell cycle-specific agent)
A
Application
Automatic Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Irinotecan HydrochlorideActive
Monograph: Irinotecan